Chitosan: A platform for targeted drug delivery

International Journal of PharmTech Research

Volumn 2, Issue 4, 2010, Pages 2271-2282

  Kushwaha Swatantra, K S ^a   Rai Awani, K ^a   Satyawan, Singh ^b  

^a PRANVEER SINGH INSTITUTE OF TECHNOLOGY   (India)

^b Saroj Institute of Technology and Management   (India)

Author keywords

Cancer; Chitosan; Drug delivery; Glycerophosphate; Hydrogel

Indexed keywords

AMPHOPHILE; CAMPTOTHECIN; CHITOSAN; F ACTIN; INSULIN; MICROSPHERE; N TRIMETHYL CHITOSAN; NANOPARTICLE; PACLITAXEL; PROTEIN ZO1; UNCLASSIFIED DRUG;

BIOLOGICAL ACTIVITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CELL MEMBRANE PERMEABILITY; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CROSS LINKING; DEACETYLATION; DRUG ABSORPTION; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EPITHELIUM CELL; HYDROGEL; MOLECULAR WEIGHT; MUCUS; NANOENCAPSULATION; PH MEASUREMENT; PHYSICAL CHEMISTRY; REVIEW; ULTRAVIOLET IRRADIATION;

EID: 78249283190     PISSN: None     EISSN: 09744304     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Chandy, T. and C. P. Sharma, 1995. Resorbable chitosan matrix-a promising biomaterials for the future. Biomed. Engg. Conf., Proc. of the Fourteenth Southern, pp: 282-285. New York: IEEE.
2. Hirano, S., N. Y. Yasuharu, J. Kinugawa, H. Higashijima and T. Hayashi, 1987. Chitin and Chitosan for use as a Novel Biomedical Material. In: Advances in Biomedical Polymers (Ed. C. G. Gebelain) pp: 285-297. Plenum Press, New York.
3. Shahidi, F.; Abuzaytoun, R. Chitin, chitosan, and co-products: chemistry, production, application, and health effects. Adv. Food Nutr. Res. 2005, 49, 93-135.
4. Tharanathan, R. N.; Kittur, F. S. Chitin-the undisputed biomolecule of great potential. Crit. Rev. Food. Sci. Nutr. 2003, 43, 61-87.
5. Gossen, M. F. A. (1997) Applications of Chitin and Chitosan. Technomic Publishing Company Book, Lancaster, 1997.
6. P. Artursson, T. Lindmark, S. S. Davis, L. Illum, Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2), Pharm. Res. 11 (1994) 1358-1361.
7. G. Borchard, H. L. Luessen, A. G. de Boer, J. C. Verhoef, C. M. Lehr, H. E. Junginger, Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Release 39 (1996) 131-138.
8. N. G. Schipper, S. Olsson, J. A. Hoogstraate, A. G. de Boer, K. M. Varum, P. Artursson, Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement, Pharm. Res. 14 (1997) 923-929.
9. G. Di Colo, S. Burgalassi, Y. Zambito, D. Monti, P. Chetoni, Effects of different Ntrimethyl chitosans on in vitro/in vivo ofloxacin transcorneal permeation, J. Pharm. Sci. 93 (2004) 2851-2862.
10. M. Singh, M. Briones, D. T. O'Hagan, A novel bioadhesive intranasal delivery system for inactivated influenza vaccines, J. Control. Release 70 (2001) 267-276.
11. O. Felt, P. Buri, R. Gurny, Chitosan: a unique polysaccharide for drug delivery, Drug Dev. Ind. Pharm. 24 (1998) 979-993.
12. L. Illum, Chitosan and its use as a pharmaceutical excipient, Pharm. Res. 15 (1998) 1326-1331.
13. H. E. Junginger, J. C. Verhoef, Macromolecules as safe penetration enhancers for hydrophilic drugs-a fiction? Pharm. Sci. Technol. Today 1 (1998) 370-376.
14. C. M. Lehr, J. A. Bouwstra, E. H. Schacht, H. E. Junginger, Invitro evaluation of mucoadhesive properties of chitosan and some other natural polymers, Int. J. Pharm. 78 (1992) 43-48.
15. H. L. Luessen, J. C. Verhoef, G. Borchard, C. M. Lehr, A. G. de Boer, H. E. Junginger, Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin, Pharm. Res. 12 (1995) 1293-1298.
16. E. E. Hassan, R. C. Parish, J. M. Gallo, Optimized formulation of magnetic Chitosan microspheres containing the anticancer agent, oxantrazole, Pharm. Res. 9 (1992) 390-397.
17. M. Bivas-Benita, K. E. van Meijgaarden, K. L. Franken, H. E. Junginger, G. Borchard, T. H. Ottenhoff, A. Geluk, Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis, Vaccine 22 (2004) 1609-1615.
18. H. Q. Mao, K. Roy, V. L. Troung-Le, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August, K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Release 70 (2001) 399-421.
19. A. F. Kotze, M. M. Thanou, H. L. Luebetaen, A. G. de Boer, J. C. Verhoef, H. E. Junginger, Enhancement of paracellular drug transport with highly quaternized N-trimethyl chitosan chloride in neutral environments: in vitro evaluation in intestinal epithelial cells (Caco-2), J. Pharm. Sci. 88 (1999) 253-257.
20. A. Bernkop-Schnurch, M. Hornof, T. Zoidl, Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates, Int. J. Pharm. 260 (2003) 229-237.
21. M. D. Hornof, C. E. Kast, A. Bernkop-Schnurch, In vitro evaluation of the viscoelastic properties of chitosan-thioglycolic acid conjugates, Eur. J. Pharm. Biopharm. 55 (2003) 185-190.
22. M. Roldo, M. Hornof, P. Caliceti, A. Bernkop-Schnurch, Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation, Eur. J. Pharm. Biopharm. 57 (2004) 115-121.
23. Y. Xu, Y. Du, R. Huang, L. Gao, Preparation and modification of N-(2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier, Biomaterials 24 (2003) 5015-5022.
24. D. Snyman, T. Govender, A. F. Kotze, Low molecular weight quaternised Chitosan (I): synthesis and characterisation, Pharmazie 58 (2003) 705-708.
25. R. J. Verheul, M. Amidi, S. van der Wal, E. van Riet, W. Jiskoot, W. E. Hennink, Synthesis, characterization and in vitro biological properties of O-methyl free N, N, N-trimethylated chitosan, Biomaterials 29 (2008) 3642-3649.
26. G. Sandri, S. Rossi, M. C. Bonferoni, F. Ferrari, Y. Zambito, G. Di Colo, C. Caramella, Buccal penetration enhancement properties of N-trimethyl chitosan: influence of quaternization degree on absorption of a high molecular weight molecule, Int. J. Pharm. 297 (2005) 146-155.
27. W. E. Hennink, C. F. van Nostrum, Novel crosslinking methods to design hydrogels, Adv. Drug Deliv. Rev. 54 (2002) 13-36.
28. M. Yang, S. Velaga, H. Yamamoto, H. Takeuchi, Y. Kawashima, L. Hovgaard, M. van de Weert, S. Frokjaer, Characterisation of salmon calcitonin in spray-dried powder for inhalation. Effect of chitosan, Int. J. Pharm. 331 (2007) 176-181.
29. S. R. Jameela, T. V. Kumary, A. V. Lal, A. Jayakrishnan, Progesterone-loaded Chitosan microspheres: a long acting biodegradable controlled delivery system, J. Control. Release 52 (1998) 17-24.
30. F. Bugamelli, M. A. Raggi, I. Orienti, V. Zecchi, Controlled insulin release from chitosan microparticles, Arch. Pharm. (Weinh.) 331 (1998) 133-138.
31. L. Y. Wang, Y. H. Gu, Q. Z. Zhou, G. H. Ma, Y. H. Wan, Z. G. Su, Preparation and characterization of uniform-sized chitosan microspheres containing insulin by membrane emulsification and a two-step solidification process, Colloids Surf., B Biointerfaces 50 (2006) 126-135.
32. P. Calvo, C. Remunan Lopez, J. L. Vila Jato, M. J. Alonso, Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers, J. Appl. Polym. Sci. 63 (1997) 125-132.
33. S. Ozbas-Turan, J. Akbuga, C. Aral, Controlled release of interleukin-2 from chitosan microspheres, J. Pharm. Sci. 91 (2002) 1245-1251.
34. C. Schatz, A. Bionaz, J. M. Lucas, C. Pichot, C. Viton, A. Domard, T. Delair, Formation of polyelectrolyte complex particles from selfcomplexation of N-sulfated chitosan, Biomacromolecules 6 (2005) 1642-1647.
35. M. Amidi, H. C. Pellikaan, H. Hirschberg, A. H. de Boer, D. J. Crommelin, W. E. Hennink, G. Kersten, W. Jiskoot, Diphtheria toxoidcontaining microparticulate powder formulations for pulmonary vaccination: preparation, characterization and evaluation in guinea pigs, Vaccine 25 (2007) 6818-6829.
36. C. Kusonwiriyawong, W. Pichayakorn, V. Lipipun, G. C. Ritthidej, Retained integrity of protein encapsulated in spray-dried chitosan microparticles, J. Microencapsul. 26 (2009) 111-121.
37. A. Grenha, B. Seijo, C. Serra, C. Remunan-Lopez, Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterization, Biomacromolecules 8 (2007) 2072-2079.
38. E. Reverchon, J. Daghero, C. Marrone, M. Mattea, M. Poletto, Supercritical fractional extraction of fennel seed oil and essential oil: experiments and mathematical modeling, Ind. Eng. Chem. Res. 38 (1999) 3069-3075.
39. P. M. Gallagher, M. P. Coffey, V. J. Krukonis, N. Klasutis, Gas antisolvent recrystallizationnew process to recrystallize compounds insoluble in supercritical fluids, Acs Symp. Ser. 406 (1989) 334-354.
40. M. Huang, E. Khor, L. Y. Lim, Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation, Pharm. Res. 21 (2004) 344-353.
41. X. Wang, C. Zheng, Z. M. Wu, D. G. Teng, X. Zhang, Z. Wang, C. X. Li, Chitosan-AC nanoparticles as a vehicle for nasal absorption enhancement of insulin, J. Biomed. Mater. Res. B, Appl. Biomater. 88B (2009) 150-161.
42. D. Teijeiro-Osorio, C. Remunan-Lopez, M. J. Alonso, New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules, Biomacromolecules 10 (2009) 243-249.
43. A. Grenha, C. I. Grainger, L. A. Dailey, B. Seijo, G. P. Martin, C. Remunan-Lopez, B. Forbes, Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro, Eur. J. Pharm. Sci. 31 (2007) 73-84.
44. K. Ono, Y. Saito, H. Yura, K. Ishikawa, Photocrosslinkable chitosan as a biological adhesive, J. Biomed. Mater Res., Part A 49 (2000) 289-295.
45. M. Ishihara, K. Obara, S. Nakamura, M. Fujita, K. Masuoka, Y. Kanatani, B. Takase, H. Hattori, Y. Morimoto, M. Ishihara, T. Maehara, M. Kikuchi, Chitosan hydrogel as a drug delivery carrier to control angiogenesis, J. Artif. Organs 9 (2006) 8-16.
46. E. Ruel-Gariepy, M. Shive, A. Bichara, M. Berrada, D. L. Garrec, A. Chenite, J.-C. Leroux, A thermosensitive chitosan-based hydrogel for the local delivery of paclitaxel, Eur. J. Pharm. Biopharm. 57 (2004) 53-63.
47. A. Chenite, M. Buschmann, D. Wang, C. Chaput, N. Kandani, Rheological characterisation of thermogelling chitosan/glycerol-phosphate solutions, Carbohydr. Polym. 46 (2001) 39-47.
48. J. Cho, M.-C. Heuzey, A. Begin, P. J. Carreau, Physical gelation of chitosan in the presence of b-glycerophosphate: the effect of temperature, Biomacromolecules 6 (2005) 3267-3275.
49. A. Chenite, C. Chaput, D. Wang, C. Combes, M. D. Buschmann, C. D. Hoemann, J. C. Leroux, B. L. Atkinson, F. Binette, A. Selmani, Novel injectable neutral solutions of chitosan form biodegradable gels in situ, Biomaterials 21 (2000) 2155-2161.
50. F.-L. Mi, S.-S. Shyu, C.-Y. Kuan, S.-T. Lee, K.-T. Lu, S.-F. Jang, Chitosan-polyelectrolyte complexation for the preparation of gel beads and controlled release of anticancer drug. I. Effect of phosphorous polyelectrolyte complex and enzymatic hydrolysis of polymer, J. Appl. Polymer Sci. 74 (1999) 1868-1879.
51. F.-L. Mi, S.-S. Shyu, S.-T. Lee, T.-B. Wong, Kinetic study of chitosantripolyphosphate complex reaction and acid-resistive properties of the chitosan-tripolyphosphate gel beads prepared by in-liquid curing method, J. Polymer Sci. B Polymer. Phys 37 (1999) 1551-1564.
52. M. Buschmann, D. Filion, M. Lavertu, Gel formation of polyelectrolyte aqueous solutions by thermally induced changes in ionization state, Canada Patent WO 2007/0513112007.
53. S. Ganguly, A. K. Dash, A novel in situ gel for sustained drug delivery and targeting, Int. J. Pharm. 276 (2004) 83-92.
54. T. Koyano, N. Minoura, M. Nagura, K. Kobayashi, Attachment and growth of cultured fibroblast cells on PVA/chitosan-blended hydrogels, J. Biomed. Mater. Res. 39 (1998) 486-490.
55. O. Nativ, M. Aronson, O. Medalia, T. MolDavsky, E. Sabo, I. Ringel, V. Kravtsov, Anti-neoplastic activity of Paclitaxel on experimental superficial bladder cancer: in vitro and in vivo studies, Int. J. Cancer 70 (1997) 297-301.
56. J. J. Manfredi, J. Parness, S. B. Horwitz, Taxol binds to cellularmicrotubules, J. Cell Biol. 94 (1982) 688-696.
57. J. Parness, S. B. Horwitz, Taxol binds to polymerized tubulin in vitro, J. Cell Biol. 91 (1981) 479-487.
58. P. B. Schiff, J. Fant, S. B. Horwitz, Promotion of microtubule assembly in vitro by taxol, Nature 277 (1979) 665-667.
59. S. Nsereko, M. Amili, Localized delivery of paclitaxel in solid tumors from biodegradable chitin micropartical formulations, Biomaterials 23 (2002) 2723-2731.
60. J. Fassberg, V. J. Stella, A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues, J. Pharm. Sci. 81 (1992) 676-684.
61. R. P. Hertberg, M. J. Caranfa, K. G. Holden, D. R. Jakas, G. Gallagher, M. R. Mattern, S. M. Mong, J. O. Bartus, R. K. Johnson, W. D. Kingsbury, Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity, J. Med. Chem. 32 (1989) 715-720.
62. T. G. Burke, Z. Mi, The structural basis of camptothecin interactions with human serum albumin: impact on drug stability, J. Med. Chem. 37 (1994) 40-46.
63. J. D. Weingart, R. C. Thompson, B. Tyler, O. M. Colvin, H. Brem, Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the intracranial 9 L aliosarcoma model, Int. J. Cancer 62 (1995) 605-609.
64. R. A. Jain, The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices, Biomaterials 21 (2000) 2475-2490.
65. M. Berrada, A. Serreqi, F. Dabbarh, A. Owusu, A. Gupta, S. Lehnert, A novel nontoxic camptothecin formulation for cancer chemotherapy, Biomaterials 26 (2005) 2115-120.